Old Web
English
Sign In
Acemap
>
authorDetail
>
Alfonso Quintas-Cardama
Alfonso Quintas-Cardama
Novartis
Immunology
Molecular biology
ABL
breakpoint cluster region
Medicine
4
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Polythérapies de récepteurs d'antigènes chimériques adn inhibiteurs pd -1
2017
Oezlem Anak
Sanela Bilic
Jennifer Brogdon
John Scott Cameron
William Chou
Danny Roland Howard
Randi Isaacs
Carl H. June
Simon F. Lacey
Shannon Maude
Jan J. Melenhorst
Stephen Shuster
Alfonso Quintas-Cardama
Show All
Source
Cite
Save
Citations (0)
Cellular Kinetics of Chimeric Antigen Receptor T Cells (CTL019) in Patients with Relapsed/Refractory CD19+ Leukemia
2016
Blood
Karen Thudium Mueller
Abhijit Chakraborty
Patricia A. Wood
Rakesh Awasthi
Alfonso Quintas-Cardama
Xia Han
Shannon L. Maude
Stephan A. Grupp
David L. Porter
Noelle V. Frey
Katherine T. Marcucci
Bruce L. Levine
J. Joseph Melenhorst
Carl H. June
Simon F. Lacey
Show All
Source
Cite
Save
Citations (3)
Abstract B61: Bcr-Abl1 V304D mutation in CML: friend or foe?
2015
Molecular Cancer Therapeutics
Sabrina Pricl
Erik Laurini
Maurizio Fermeglia
Paola Storici
Barbara Giabbai
Marta S Semrau
Matteo De March
Nicholas J. Donato
Alfonso Quintas-Cardama
Show All
Source
Cite
Save
Citations (0)
249 Bcr-Abl1 V304D mutation in CML: Friend or foe?
2015
European Journal of Cancer
Sabrina Pricl
Erik Laurini
Maurizio Fermeglia
V. Dal Col
Paola Storici
Barbara Giabbai
Marta S Semrau
M. De March
Nicholas J. Donato
Alfonso Quintas-Cardama
Show All
Source
Cite
Save
Citations (0)
1